Hims & Hers Health Price to Book Ratio 2020-2024 | HIMS

Historical price to book ratio values for Hims & Hers Health (HIMS) over the last 10 years. The current price to book ratio for Hims & Hers Health as of November 11, 2024 is 13.61.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Hims & Hers Health Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-11-12 26.69 15.99
2024-06-30 20.19 $1.67 12.09
2024-03-31 15.47 $1.61 9.63
2023-12-31 8.90 $1.61 5.52
2023-09-30 6.29 $1.55 4.06
2023-06-30 9.40 $1.52 6.19
2023-03-31 9.92 $1.49 6.64
2022-12-31 6.41 $1.50 4.29
2022-09-30 5.58 $1.50 3.73
2022-06-30 4.53 $1.54 2.94
2022-03-31 5.33 $1.59 3.35
2021-12-31 6.55 $1.63 4.01
2021-09-30 7.54 $1.74 4.33
2021-06-30 10.89 $1.52 7.18
2021-03-31 13.23 $1.53 8.66
2020-12-31 14.60 $-2.77 -5.27
2020-09-30 11.75 $0.82 14.33
2020-06-30 10.17 $0.85 11.94
2020-03-31 10.00 $0.85 11.73
2019-12-31 9.90 0.00
2019-09-30 9.87 $0.82 11.98
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.988B $0.872B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.978B 0.00
Inspire Medical Systems (INSP) United States $6.055B 188.82
Axonics (AXNX) United States $3.602B 1762.00
IRhythm Technologies (IRTC) United States $2.783B 0.00
Privia Health (PRVA) United States $2.736B 228.00
Enovis (ENOV) United States $2.646B 17.94
Omnicell (OMCL) United States $2.263B 74.03
Azenta (AZTA) United States $2.242B 127.33
10x Genomics (TXG) United States $1.925B 0.00
Clover Health Investments (CLOV) United States $1.657B 0.00
Schrodinger (SDGR) United States $1.422B 0.00
Phreesia (PHR) United States $1.252B 0.00
Standard BioTools (LAB) United States $0.830B 0.00
Fulgent Genetics (FLGT) United States $0.613B 0.00
Talkspace (TALK) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.582B 0.00
Definitive Healthcare (DH) United States $0.508B 88.00
Health Catalyst (HCAT) United States $0.506B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
TruBridge (TBRG) United States $0.214B 62.22
P3 Health Partners (PIII) United States $0.142B 0.00
American Well (AMWL) United States $0.139B 0.00
EUDA Health Holdings (EUDA) Singapore $0.106B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.050B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
CareCloud (CCLD) United States $0.042B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00